TOKYO (dpa-AFX) - Bio-Rad Laboratories Inc. (BIO) is in talks to merge with Qiagen NV (QGEN) in a deal worth more than $10 billion, the Wall Street Journal reported, citing people familiar with the matter.
The talks have been going on for a while but any agreement isn't likely for another few weeks or more-and there may not be one, the Journal reported.
Bio Rad has a market cap of about $11.77 billion.
BIO closed Monday's regular trading at $392.95 down $35.98 or 8.39%. In the after-hours, the stock further dropped $0.46 or 0.12%.
Copyright(c) 2022 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
© 2022 AFX News
